Literature DB >> 11056130

Successful transfer of frozen-thawed embryos obtained immediately before radical surgery for stage IIIa serous borderline ovarian tumour: case report.

D Gallot1, J L Pouly, L Janny, G Mage, M Canis, A Wattiez, M A Bruhat.   

Abstract

A stage IIIA borderline serous ovarian tumour was treated conservatively by laparoscopy to preserve the fertility of a 21 year old nulligravid woman. Six months later, recurrent lesions were resected. An 'urgent' IVF was performed to obtain frozen embryos. Oncological treatment was then completed by radical surgery with uterine conservation. Fifteen months later, two thawed embryos were successfully transferred and the patient delivered one baby. From this observation, the authors discuss an alternative to oocyte donation in cases of bilateral ovariectomy for stage IIIA borderline serous ovarian tumour.

Entities:  

Mesh:

Year:  2000        PMID: 11056130     DOI: 10.1093/humrep/15.11.2347

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

Review 1.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

2.  Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.

Authors:  Ziyang Lu; Bin Li; Chao Gu
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

3.  Vitreous cryopreservation of human preantral follicles encapsulated in alginate beads with mini mesh cups.

Authors:  Jiang Bian; Tao Li; Chenhui Ding; Weijie Xin; Bo Zhu; Canquan Zhou
Journal:  J Reprod Dev       Date:  2013-03-14       Impact factor: 2.214

4.  Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?

Authors:  Sebastien Gouy; Marine Saidani; Amandine Maulard; Matthieu Faron; Slim Bach-Hamba; Enrica Bentivegna; Alexandra Leary; Patricia Pautier; Mojgan Devouassoux-Shisheboran; Catherine Genestie; Philippe Morice
Journal:  Gynecol Oncol Rep       Date:  2017-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.